Know Cancer

or
forgot password

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma


N/A
N/A
N/A
Open (Enrolling)
Both
Non-Small Cell Lung Carcinoma, Venous Thromboembolism

Thank you

Trial Information

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma


Inclusion Criteria:



- Histologically or cytologically confirmed diagnosis of NSCLC.

- normal serum bilirubin

- informed concent to participate in the study

Exclusion Criteria:

- anticoagulant therapy

- infectious disease

Type of Study:

Observational

Study Design:

Additional Descriptors: Convenience Sample, Primary Purpose: Screening, Time Perspective: Longitudinal, Time Perspective: Prospective

Principal Investigator

Galit Sarig, Ph.D

Investigator Role:

Principal Investigator

Investigator Affiliation:

Rambam Health Care Campus

Authority:

Israel: Israeli Health Ministry Pharmaceutical Administration

Study ID:

Thrombosis and cancer.CTIL

NCT ID:

NCT00192829

Start Date:

June 2005

Completion Date:

Related Keywords:

  • Non-Small Cell Lung Carcinoma
  • Venous Thromboembolism
  • Lung cancer
  • Thrombosis
  • Hypercoagulable
  • Carcinoma
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Thromboembolism
  • Venous Thromboembolism
  • Venous Thrombosis

Name

Location